Stay updated on Belantamab vs Bortezomib in MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page
- Check3 days agoChange DetectedRecruitment status updated to no longer recruit participants, and the locations section expanded to 122 sites with new entries in China, Brazil, and New Zealand. The page also added guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and included the sponsor's data-sharing policy.SummaryDifference0.9%

- Check10 days agoChange DetectedThe page now lists Multiple myeloma and MedlinePlus Genetics as related topics. The revision/version tag was updated from v3.5.4 to v3.5.5 to reflect the latest page revision.SummaryDifference0.1%

- Check17 days agoChange DetectedThe Related Topics section no longer lists 'Multiple myeloma' and 'MedlinePlus Genetics' on the DREAMM-8 study page. This reduces quick access to disease-focused and genetics resources but does not alter the study's primary content or data.SummaryDifference0.1%

- Check24 days agoChange DetectedRelated topics section now includes 'Multiple myeloma' and a link to 'MedlinePlus Genetics'. This addition places the study in the disease context and improves navigation to genetics-related information.SummaryDifference0.1%

- Check31 days agoChange DetectedA new site revision tag 'Revision: v3.5.4' was added, indicating an updated build. Several topic labels and the previous revision tag 'Revision: v3.5.3' were removed (e.g., 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics'), reflecting a cleanup of page topics and metadata.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page removes the explicit disease tag and related topics references, altering how the condition is identified and where related resources are shown.SummaryDifference0.1%

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.